937219

Kowa Pharmaceuticals America — FEI 3007640042

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 5, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Montgomery, AL (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)